Correlation Between Genomma Lab and Aion Therapeutic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genomma Lab and Aion Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genomma Lab and Aion Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genomma Lab Internacional and Aion Therapeutic, you can compare the effects of market volatilities on Genomma Lab and Aion Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genomma Lab with a short position of Aion Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genomma Lab and Aion Therapeutic.

Diversification Opportunities for Genomma Lab and Aion Therapeutic

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Genomma and Aion is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Genomma Lab Internacional and Aion Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aion Therapeutic and Genomma Lab is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genomma Lab Internacional are associated (or correlated) with Aion Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aion Therapeutic has no effect on the direction of Genomma Lab i.e., Genomma Lab and Aion Therapeutic go up and down completely randomly.

Pair Corralation between Genomma Lab and Aion Therapeutic

Assuming the 90 days horizon Genomma Lab is expected to generate 43.27 times less return on investment than Aion Therapeutic. But when comparing it to its historical volatility, Genomma Lab Internacional is 34.97 times less risky than Aion Therapeutic. It trades about 0.22 of its potential returns per unit of risk. Aion Therapeutic is currently generating about 0.27 of returns per unit of risk over similar time horizon. If you would invest  1.00  in Aion Therapeutic on September 4, 2024 and sell it today you would earn a total of  2.00  from holding Aion Therapeutic or generate 200.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Genomma Lab Internacional  vs.  Aion Therapeutic

 Performance 
       Timeline  
Genomma Lab Internacional 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Genomma Lab Internacional are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak essential indicators, Genomma Lab reported solid returns over the last few months and may actually be approaching a breakup point.
Aion Therapeutic 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aion Therapeutic are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental indicators, Aion Therapeutic reported solid returns over the last few months and may actually be approaching a breakup point.

Genomma Lab and Aion Therapeutic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genomma Lab and Aion Therapeutic

The main advantage of trading using opposite Genomma Lab and Aion Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genomma Lab position performs unexpectedly, Aion Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aion Therapeutic will offset losses from the drop in Aion Therapeutic's long position.
The idea behind Genomma Lab Internacional and Aion Therapeutic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume